CClinicalTrials.gg
CompletedNCT04981275Updated Nov 1, 2023

A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype

An observational study in Polycystic Ovary Syndrome, sponsored by Onegevity Health. Completed at 1 site in United States. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-01.

Sponsored by Onegevity Health · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
81
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

The purpose of this research study is to explore the relationship between the gut microbiome and hormone levels in women diagnosed with PCOS and determine whether there are differences in the gut microbiome between women with PCOS and women without PCOS.

Consented, enrolled participants will complete a health questionnaire, complete a fasted blood draw at a local laboratory, and provide a stool, saliva, and vaginal swab sample for comprehensive biomarkers, hormones, metagenomics, and metabolomics analysis.

02

Conditions studied

  • Polycystic Ovary Syndrome
03

In context

Polycystic Ovary Syndrome

944 studies on the registry are indexed under Polycystic Ovary Syndrome; 174 are open to participants now.

This study's enrollment of 81 is below the median of 118 across 223 observational studies indexed under Polycystic Ovary Syndrome.

Browse Polycystic Ovary Syndrome studies →

Lead sponsor

Onegevity Health is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women, ages 18-40, living in the USA (except for NY, NJ, RI, MD, SD, ND, or HI), who have not been using hormonal therapy for at least 3 months and without other significant health issues or medications affecting hormones. Women must be previously diagnosed with PCOS or considered Healthy and not currently pregnant or nursing. Women will be referred to the study by their Physician or word of mouth.

Inclusion criteria

  • Women diagnosed with PCOS or Women who are considered Healthy
  • 18-40 years old
  • Residing in the USA, except for exclusion states
  • Have not been using hormonal therapy for at least 3 months

Exclusion criteria

Exclusion Criteria:

  • Women using hormonal therapy within the last 3 months
  • Diagnosed with other significant health conditions or using medications that will affect hormone levels
  • Residing in NY, NJ, MD, RI, ND, SD, or HI
  • Pregnant or nursing
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
81 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Women with PCOS

    Women previously diagnosed with PCOS not using hormonal therapy and without other significant health or endocrine issues

    Other: No intervention study

  • Healthy controls

    Women self-identifying as generally healthy, not using hormonal therapy, and without any significant health or endocrine issues

    Other: No intervention study

Interventions

  • OtherNo intervention study

    This observational study will only collect data, not provide any intervention to participants.

06

What researchers measure

Primary outcomes

  1. Phenotype differences in vaginal microbiome

    Understand phenotypical differences from biological samples comparing women with and without PCOS. Vaginal swabs are to be collected by women and analyzed with metagenomics and metabolomics sequencing.

    Time frame: Samples to be collected on any day once per participant within 30 days of enrollment

  2. Phenotype differences in gut microbiome

    Understand phenotypical differences from biological samples comparing women with and without PCOS. Stool samples are to be collected by women and analyzed with metagenomics sequencing.

    Time frame: Samples to be collected once on any day per participant within 30 days of enrollment

  3. Phenotype differences in blood biomarkers

    Understand phenotypical differences from biological samples comparing women with and without PCOS. Venipuncture blood draws are to be completed and analyzed by a commercial laboratory, for a comprehensive analysis of targeted hormones and untargeted metabolic systems.

    Time frame: Samples to be collected once within a 5-day window to control for menstrual cycle, within 30 days of enrollment

  4. Phenotype differences in DNA

    Understand phenotypical differences from biological samples comparing women with and without PCOS. Saliva samples are to be collected and analyzed by a commercial laboratory for DNA and metabolomics.

    Time frame: Samples to be collected once per participant within 30 days of enrollment

07

Study locations

1 site
  • University of Maryland
    College Park, Maryland 20742, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04981275
Lead sponsor
Onegevity Health
Collaborators
University of Maryland, Baltimore
Responsible party
Sponsor
First posted
Jul 28, 2021
Start date
Jun 19, 2021
Primary completion
Jan 11, 2022
Completion
Sep 30, 2023
Last update
Nov 1, 2023

Study contacts

Chris D'Adamo, PhD
principal investigator · University of Maryland
Chris Mason, PhD
principal investigator · Weill Medical College of Cornell University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion